Simulation studies of surrogate endpoint validation using single trial and multitrial statistical approaches.
OBJECTIVE: A schema was recently proposed for assessing the levels of evidence for surrogate validity that included 4 domains: Target, Study Design, Statistical Strength, and Penalties. This report examines one component of the schema. It surveys the literature on methods of statistical validation...
Main Authors: | Lassere, M, Johnson, K, Hughes, M, Altman, D, Buyse, M, Galbraith, S, Wells, G |
---|---|
Format: | Conference item |
Published: |
2007
|
Similar Items
-
Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema.
by: Lassere, M, et al.
Published: (2007) -
Is blood pressure reduction a valid surrogate endpoint for stroke prevention? an analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) and the biomarker-surrogacy (BioSurrogate) evaluation schema (BSES)
by: Lassere Marissa N, et al.
Published: (2012-03-01) -
A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials
by: Ciani, O, et al.
Published: (2023) -
Biomarkers and surrogate endpoints.
by: Aronson, J
Published: (2005) -
Surrogate endpoints in trials: a call for better reporting
by: Oriana Ciani, et al.
Published: (2022-12-01)